NCT01545661 Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting Status COMPLETED Phase NA
NCT01539005 Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy Status COMPLETED Phase N/A
NCT01530568 Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients Status COMPLETED Phase NA
NCT01525134 Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis Status UNKNOWN Phase NA
NCT01517022 Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis Status COMPLETED Phase PHASE3
NCT01497769 Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route Status COMPLETED Phase PHASE1
NCT01494038 Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women Status COMPLETED Phase PHASE4
NCT01492595 Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda Status COMPLETED Phase N/A
NCT01479972 Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa Status COMPLETED Phase PHASE2
NCT01464762 Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis Status APPROVED_FOR_MARKETING Phase N/A
NCT01459120 Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho Status COMPLETED Phase NA
NCT01456845 Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity Status COMPLETED Phase N/A
NCT01442428 Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Status WITHDRAWN Phase PHASE2/PHASE3
NCT01436929 Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs Status UNKNOWN Phase NA
NCT01433796 Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment Status COMPLETED Phase N/A
NCT01424501 Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease Status TERMINATED Phase PHASE2